Methylene Blue 10mg/mL 50mL
Mitochondrial Electron Carrier for Cognitive and Longevity Research
Methylene Blue is a redox-cycling compound that donates electrons directly to cytochrome c in the mitochondrial electron transport chain, improving ATP production and reducing oxidative stress. It is one of the oldest studied cognitive enhancers with modern longevity applications.
Mitochondrial Electron Carrier for Cognitive and Longevity Research
Methylene Blue (MB) acts as an alternative electron carrier, bypassing Complex I dysfunction in aging mitochondria. Research shows it enhances memory consolidation, reduces amyloid toxicity in Alzheimer models, and has antidepressant properties via MAO inhibition.
As one of the most studied compounds in the longevity research space, Methylene Blue has attracted sustained scientific interest across Mitochondrial health research, Cognitive enhancement studies, Longevity protocols. Peer-reviewed evidence indicates that improves memory in rat models at low doses, which has positioned Methylene Blue as a reference standard for researchers exploring mitochondrial health research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
Methylene Blue Documented Benefits: 4 Documented Mechanisms
Mitochondrial Rescue
Bypasses Complex I dysfunction by directly donating electrons to cytochrome c, restoring ATP production.
Cognitive Enhancement
Studies show improved memory consolidation and attention in animal models and early human trials.
Neuroprotection
Reduces amyloid beta toxicity and tau phosphorylation in Alzheimer disease models.
Antidepressant Activity
Low-dose MAO inhibition contributes to serotonin and dopamine tone.
How Methylene Blue Works: Molecular Mechanism & Pathway
Redox-active phenothiazine accepting and donating electrons in the mitochondrial electron transport chain, increasing ATP synthesis efficiency and scavenging reactive oxygen species.
The 4 primary research pathways identified for Methylene Blue — Mitochondrial Rescue, Cognitive Enhancement, Neuroprotection — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that reduces tau aggregation in Alzheimer research, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, Methylene Blue's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
Methylene Blue is routinely studied alongside NAD+ and FOXO4-DRI in longevity-focused compound panels. Researchers investigating mitochondrial health research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that clinical trials for cognitive enhancement ongoing has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All Methylene Blue research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Improves memory in rat models at low doses
- Reduces tau aggregation in Alzheimer research
- Clinical trials for cognitive enhancement ongoing
Ideal For
- Mitochondrial health research
- Cognitive enhancement studies
- Longevity protocols
- Neurodegeneration research
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on Methylene Blue. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Improves memory in rat models at low doses
Reduces tau aggregation in Alzheimer research
Clinical trials for cognitive enhancement ongoing
Third-Party Verified Every Batch
Each vial of Methylene Blue is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
